Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02625961 |
|---|---|
| Brief Title: | Study of Pembrolizumab (MK-3475) and Pembrolizumab With Other Investigational Agents in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057) |
| First Submitted : | December 7, 2015 |
| First Submitted that Met QC Criteria : | December 7, 2015 |
| First Posted : | December 9, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | April 19, 2024 |
| Last Update Posted : | April 22, 2024 |